Disclosure: This site earns commissions from affiliate links (Amazon, Etsy, and others) at no extra cost to you.   Full affiliate disclosure →

Updated July 2026 · 9 min read

This article was created with AI assistance.

Norepinephrine vs. Vasopressin: A Bedside Comparison

⚕️ Medical Disclaimer: This content is for educational purposes only and is intended for licensed healthcare professionals. It does not constitute medical advice and should not replace clinical judgment, facility protocols, or physician orders. Always verify medications, doses, and procedures with your institution's guidelines.

Part of the ICU Pharmacology Hub — browse every related guide in one place.

These two drugs hang side by side on countless septic-shock patients, but they could hardly be more different: one is a titratable catecholamine, the other a fixed-dose hormone; one works through adrenergic receptors, the other does not. Knowing exactly how they differ is what lets you read a pressor order like a sentence instead of a list.

The short version: Norepinephrine is the first-line, titratable vasopressor — an alpha-1 agonist with a beta-1 lift that you dial to a MAP goal. Vasopressin is a fixed-dose, second-line add-on that constricts vessels through V1 receptors, a completely non-catecholamine pathway. They are used together, not against each other: norepinephrine does the heavy lifting; vasopressin is added to raise the pressure and spare the catecholamine dose.

The core difference: two different receptor systems

Everything else follows from this. Norepinephrine acts on adrenergic receptors — mostly alpha-1 (vasoconstriction) with some beta-1 (a little more squeeze and rate). Vasopressin acts on V1 receptors on vascular smooth muscle, an entirely separate signaling system. That single fact explains why they complement each other so well: when prolonged, acidotic shock downregulates and desensitizes the adrenergic receptors and norepinephrine starts losing its grip, vasopressin can keep constricting through a pathway the acidosis and desensitization have not touched.

Head-to-head comparison

FeatureNorepinephrineVasopressin
Drug classCatecholamineHormone (ADH analog)
ReceptorAlpha-1 > beta-1V1 (vascular)
Line in septic shockFirst-lineSecond-line add-on
DosingTitrated to MAP (e.g., mcg/kg/min)Fixed (commonly 0.03 units/min)
Inotropy / chronotropyModest beta-1 liftNone (pure vasoconstrictor)
Effect in acidosisCan lose potencyRelatively preserved
Main risk profileArrhythmias, extravasation necrosisDigital / mesenteric ischemia
Reversal for extravasationPhentolamineTreat ischemia; central line preferred

How they are used together

In practice the sequence looks like this. The patient in septic shock is fluid-resuscitated, and if the MAP still will not hold at 65, norepinephrine goes up first and is titrated. When the norepinephrine dose keeps climbing — a rising requirement is itself a warning sign that the shock is winning — the team adds vasopressin at its fixed dose rather than pushing norepinephrine ever higher. The vasopressin both nudges the pressure up and lets you hold or lower the catecholamine, reducing arrhythmia risk and adrenergic burden. From there, the ladder continues: reassess volume, consider stress-dose steroids, add an inotrope if the heart is the problem, and reconsider whether the source is truly controlled. The full sequence is laid out in the refractory septic shock vasopressor ladder.

Bedside instinct: Norepinephrine is your steering wheel — you are constantly adjusting it to the MAP. Vasopressin is more like engaging four-wheel drive — you turn it on to get more traction, then leave it and manage everything else. Titrate one; set-and-monitor the other.

Titratable vs. fixed: why the difference matters at the bedside

The single most common new-nurse error is treating vasopressin like a second norepinephrine. Norepinephrine is meant to move with the pressure — up when the MAP falls, down as the patient recovers. Vasopressin is generally set at its fixed dose and left there; chasing the MAP by cranking vasopressin sharply raises the risk of finger, toe, and gut ischemia without a proven benefit. When it is time to wean, most protocols come off norepinephrine first or taper vasopressin carefully, because abruptly stopping vasopressin can trigger a rebound pressure drop. Always follow your unit's specific weaning order.

What each one does NOT do

Norepinephrine gives only a modest inotropic lift, so it is not the answer when the real problem is a failing pump — that patient may need an inotrope or a different strategy. Vasopressin gives no inotropy or chronotropy at all; it is pure vasoconstriction, so it does nothing for a heart that cannot generate output and can actually worsen perfusion if leaned on too hard. Neither drug fixes uncontrolled source, unaddressed hypovolemia, or untreated adrenal insufficiency. Reading the pressors correctly also means recognizing when the ladder is telling you to look somewhere other than the infusion pump — the lactate trend is your honest scorecard.

A quick word on the other catecholamines

Norepinephrine and vasopressin are the classic septic-shock pairing, but they are not the only pressors you will see. Epinephrine and phenylephrine differ again in their receptor balance and best use cases — that comparison is covered in the norepinephrine vs. epinephrine vs. phenylephrine guide. The organizing principle across all of them is the same: match the drug's receptor profile to the physiologic problem in front of you.

Why CRNA students should know it cold

On the CRNA path, you will reach for norepinephrine constantly to manage anesthesia-induced hypotension, and for vasopressin specifically when a patient is vasoplegic — profoundly vasodilated and refractory to catecholamines after bypass, in anaphylaxis, or on chronic ACE inhibitors/ARBs. Knowing that these two drugs pull different levers is exactly what lets you rescue an OR pressure that will not respond to "more of the same." The bedside comparison you learn now is the intraoperative decision you will make later.

Bottom line

Norepinephrine and vasopressin are teammates, not rivals: a titratable first-line catecholamine and a fixed-dose second-line hormone that work through different receptors. Titrate the norepinephrine to the MAP, add vasopressin to raise the pressure and spare the catecholamine, watch the periphery and gut for the ischemia vasopressin can cause, and wean per protocol.

Related pharmacology: deepen this with the vasopressin physiology deep-dive, the norepinephrine guide, and the full vasopressor guide.

This article is general educational information for licensed clinicians and students, not medical advice or a substitute for your institution's protocols, pharmacy guidance, or a provider's orders. Always follow facility policy and verify every dose independently.

Get the ICU Notebook

Free investing strategies built for nurses. One email per week, no fluff.

Yes, send it free

No spam. Unsubscribe any time.